FDA Drug Application (203595) for SUCLEAR by BRAINTREE LABS

Back to FDA Applications sponsored by BRAINTREE LABS

Application Number203595
Product Number001
FormSOLUTION;ORAL
Dosage1.6GM;210GM;0.74GM;3.13GM;2.86GM;5.6GM;17.5GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUCLEAR
Active IngredientMAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE

Active IngredientCount
List of drugs with Active Ingredient MAGNESIUM SULFATE11
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient POTASSIUM SULFATE5
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352
List of drugs with Active Ingredient SODIUM SULFATE9


Back to FDA Applications sponsored by BRAINTREE LABS